| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | alanine-alanine | 1613 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 2693 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 3144 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alanine-alanine | 4793 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
| GC POSITIVE ION MODE | alanine-alanine | 6369 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | alanine-alanine | 8434 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 9239 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 9418 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | alanine-alanine | 10313 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | alanine-alanine | 10373 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 11452 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | alanine-alanine | 13025 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 15259 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 15970 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 16389 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | alanine-alanine | 16403 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | alanine-alanine | 17104 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 17393 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | alanine-alanine | 18175 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | alanine-alanine | 18457 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alanine-alanine | 18811 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 19875 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alanine-alanine | 19883 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alanine-alanine | 19910 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alanine-alanine | 19963 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | alanine-alanine | 20965 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 21248 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alanine-alanine | 21249 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | alanine-alanine | 21580 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alanine-alanine | 21637 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | alanine-alanine | 21742 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | alanine-alanine | 21987 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | alanine-alanine | 22108 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alanine-alanine | 22478 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | alanine-alanine | 22981 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alanine-alanine | 23723 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | alanine-alanine | 24214 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | alanine-alanine | 24367 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alanine-alanine | 25649 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | alanine-alanine | 25661 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alanine-alanine | 25800 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | alanine-alanine | 25969 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | alanine-alanine | 28507 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 29299 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
| GC POSITIVE ION MODE | alanine-alanine | 30597 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | alanine-alanine | 31477 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | alanine-alanine | 32623 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 38547 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 39714 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 42837 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 45497 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | alanine-alanine | 46481 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | alanine-alanine | 49835 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | alanine-alanine | 84313 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|